Jazz Pharma Files 8-K on Officer Changes and Compensation
Ticker: JAZZ · Form: 8-K · Filed: Feb 27, 2024 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-changes, compensation, corporate-governance, 8-K
TL;DR
**Jazz Pharma filed an 8-K about officer changes and compensation, but the details aren't in this snippet.**
AI Summary
This 8-K filing by Jazz Pharmaceuticals plc, filed on February 27, 2024, reports events that occurred on February 23, 2024. The filing indicates changes related to the departure or election of directors or officers, and compensatory arrangements for certain officers. However, the provided text does not contain the specific names, roles, or financial details of these changes, only the general categories of the reported events.
Why It Matters
Changes in executive leadership and compensation arrangements can signal strategic shifts or impact investor confidence, making these disclosures important for understanding a company's governance and future direction.
Risk Assessment
Risk Level: medium — Without specific details on the officers involved or the nature of the compensatory arrangements, the immediate risk or benefit cannot be assessed from this filing alone.
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Filer of the 8-K
- 001-33500 (other) — Commission File No.
- 98-1032470 (other) — IRS Employer Identification No.
FAQ
What is the name of the registrant that filed this 8-K?
The registrant is JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY (Jazz Pharmaceuticals plc).
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported in this filing occurred on February 23, 2024.
What specific items are reported in this 8-K?
The 8-K reports on 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers'.
What is the accession number for this SEC filing?
The accession number for this filing is 0001193125-24-047087.
Where are Jazz Pharmaceuticals plc's principal executive offices located?
The principal executive offices are located at Fifth Floor, Waterloo Exchange, Waterloo Road, Dublin 4, Ireland D04 E5W7.
Filing Stats: 697 words · 3 min read · ~2 pages · Grade level 13.1 · Accepted 2024-02-27 07:45:31
Key Financial Figures
- $0.0001 — istered Ordinary shares, nominal value $0.0001 per share JAZZ The Nasdaq Stock Mar
Filing Documents
- d783837d8k.htm (8-K) — 23KB
- 0001193125-24-047087.txt ( ) — 145KB
- jazz-20240223.xsd (EX-101.SCH) — 3KB
- jazz-20240223_lab.xml (EX-101.LAB) — 18KB
- jazz-20240223_pre.xml (EX-101.PRE) — 11KB
- d783837d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY By: /s/ Neena Patil Name: Neena Patil Title: Executive Vice President and Chief Legal Officer Date: February 27, 2024